These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32883689)

  • 41. Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease.
    Wang K; Zelnick LR; Hoofnagle AN; Chen Y; de Boer IH; Himmelfarb J; Kestenbaum B
    Nephrol Dial Transplant; 2020 Nov; 35(11):1916-1923. PubMed ID: 31347660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
    Devetzis V; Daryadel A; Roumeliotis S; Theodoridis M; Wagner CA; Hettwer S; Huynh-Do U; Ploumis P; Arampatzis S
    PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease.
    Lee YH; Seo JW; Kim M; Tae D; Seok J; Kim YG; Lee SH; Kim JS; Hwang HS; Jeong KH; Moon JY
    Front Endocrinol (Lausanne); 2021; 12():774436. PubMed ID: 34858345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tubular epithelial progenitors are excreted in urine during recovery from severe acute kidney injury and are able to expand and differentiate
    Gerges D; Hevesi Z; Schmidt SH; Kapps S; Pajenda S; Geist B; Schmidt A; Wagner L; Winnicki W
    PeerJ; 2022; 10():e14110. PubMed ID: 36285332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.
    Vlad A; Vlad M; Petrica L; Ursoniu S; Gadalean F; Popescu R; Vlad D; Dumitrascu V; Gluhovschi G; Gluhovschi C; Velciov S; Bob F; Matusz P; Secara A; Simulescu A; Jianu DC
    Ren Fail; 2017 Nov; 39(1):112-119. PubMed ID: 27841047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease.
    Li S; Zheng S; Li J; Lin S; Li H; Wang P; Chen P; Ma C; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1257430. PubMed ID: 37732129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
    Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
    PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.
    Satirapoj B; Wang Y; Chamberlin MP; Dai T; LaPage J; Phillips L; Nast CC; Adler SG
    Nephrol Dial Transplant; 2012 Jul; 27(7):2702-11. PubMed ID: 22167593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L; Huang L; Wu H; Lou Q; Bian R
    Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic value of α1-MG and URBP in early diabetic renal impairment.
    Zhou Y; Zhang Y; Chen J; Wang T; Li H; Wu F; Shang J; Zhao Z
    Front Physiol; 2023; 14():1173982. PubMed ID: 37929213
    [No Abstract]   [Full Text] [Related]  

  • 53. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
    Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of tubular epithelial cells in diabetic nephropathy.
    Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
    Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.
    Jiang X; Zhang Q; Wang HB; Cui XF; Liu R
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28236320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
    Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
    Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.
    Eriguchi M; Lin M; Yamashita M; Zhao TV; Khan Z; Bernstein EA; Gurley SB; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
    Am J Physiol Renal Physiol; 2018 Apr; 314(4):F531-F542. PubMed ID: 29187372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.
    Limonte CP; Valo E; Drel V; Natarajan L; Darshi M; Forsblom C; Henderson CM; Hoofnagle AN; Ju W; Kretzler M; Montemayor D; Nair V; Nelson RG; O'Toole JF; Toto RD; Rosas SE; Ruzinski J; Sandholm N; Schmidt IM; Vaisar T; Waikar SS; Zhang J; Rossing P; Ahluwalia TS; Groop PH; Pennathur S; Snell-Bergeon JK; Costacou T; Orchard TJ; Sharma K; de Boer IH;
    Diabetes Care; 2022 Jun; 45(6):1416-1427. PubMed ID: 35377940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis.
    Hallow KM; Gebremichael Y; Helmlinger G; Vallon V
    Am J Physiol Renal Physiol; 2017 May; 312(5):F819-F835. PubMed ID: 28148531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
    Kin Tekce B; Tekce H; Aktas G; Sit M
    Clin Invest Med; 2014 Dec; 37(6):E377-83. PubMed ID: 25618270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.